Compare Crowdstrike Holdings Inc (CRWD) vs Philip Morris International Inc. (PM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crowdstrike Holdings Inc vs Philip Morris International Inc. — how do they compare? Crowdstrike Holdings Inc trades at $266.54 (market cap $269.31B), while Philip Morris International Inc. trades at $200.12 (market cap $312.50B). The key difference: Philip Morris International Inc. is the larger of the two by market cap, and Philip Morris International Inc. pays a 3.19% dividend while Crowdstrike Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Crowdstrike Holdings Inc for 97 Days and Philip Morris International Inc. for 85 Days on average.
| CRWD | PM | |
|---|---|---|
Market Cap | $269.31B | $312.50B |
Volume | 9,381,560 | 5,517,172 |
Sector | Technology | Consumer Staples |
52-Week High | $278.86 | $200.50 |
52-Week Low | $87.56 | $144.33 |
Typical Hold Time | 97 Days | 85 Days |
Enterprise Value | $265.11B | $355.62B |
Dividend Yield | — | 3.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CrowdStrike (CRWD) trades at $265.44, down 4.81% on the day but remains near its 52-week high. The stock shows strong technical momentum with a bullish moving average signal and has consistently beaten earnings expectations in recent quarters. Revenue growth remains robust at $3.95 billion for 2025, though profitability metrics show mixed results with a net income margin of -0.49%. Analyst sentiment remains overwhelmingly positive with 76% buy ratings and a consensus price target of $235.74.
CrowdStrike presents a compelling growth story with strong revenue expansion and market leadership in cybersecurity, though elevated valuation multiples and recent profitability challenges warrant caution. The company benefits from AI-driven cybersecurity demand but faces execution risks and competitive pressures. Current levels offer potential for long-term investors comfortable with growth stock volatility.
Philip Morris International (PM) trades at $192.69, up 1.2% today, with a bullish technical signal and strong analyst support. Recent Q2 2026 EPS beat expectations at $2.20 vs. $2.05, and revenue growth accelerated to $40.65B in 2025. The company's smoke-free products now drive 42% of revenue, with ZYN and IQOS expansions fueling optimism. Cash flow remains robust, with 2026 operating cash flow projected at $14.3B, supporting dividend growth.
Outlook is positive given earnings momentum and smoke-free transition, but high debt ($42.17B long-term) and regulatory risks persist. The consensus price target of $212.17 implies ~10% upside, though valuation multiples are elevated versus peers. Key risks include FX volatility and slower adoption of next-gen products.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crowdstrike Holdings Inc
CrowdStrike Holdings provides cybersecurity products and services aimed at protecting organizations from cyberthreats. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, identity protection, and log management. CrowdStrike went public in 2019 and serves customers worldwide.
Read more on CRWD →About Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →
